ICD-10-CM Code R87.618

Other abnormal cytological findings on specimens from cervix uteri

Version 2021 Billable Code No Valid Principal Dx Diagnoses For Females Only OB/GYN

Valid for Submission

R87.618 is a billable code used to specify a medical diagnosis of other abnormal cytological findings on specimens from cervix uteri. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code R87.618 might also be used to specify conditions or terms like abnormal cervical papanicolaou smear, atypical glandular cells on cervical papanicolaou smear, ca cervix screening abnormal, cervical smear - borderline change in endocervical cells, cervical smear - borderline change in squamous cells, cervical smear - borderline changes, etc

The code R87.618 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

The code is commonly used in ob/gyn medical specialties to specify clinical concepts such as abnormal female genital cytology.

According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.

ICD-10:R87.618
Short Description:Oth abnormal cytolog findings on specimens from cervix uteri
Long Description:Other abnormal cytological findings on specimens from cervix uteri

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R87.618 are found in the index:


Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

  • Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abnormal cervical Papanicolaou smear
  • Atypical glandular cells on cervical Papanicolaou smear
  • Ca cervix screening abnormal
  • Cervical smear - borderline change in endocervical cells
  • Cervical smear - borderline change in squamous cells
  • Cervical smear - borderline changes
  • Cervical smear - borderline changes
  • Cervical smear - endocervical cells absent
  • Cervical smear - inflammatory change
  • Cervical smear - inflammatory change
  • Cervical smear - inflammatory change
  • Cervical smear - inflammatory change
  • Cervical smear - koilocytosis
  • Cervical smear - mild dyskaryosis
  • Cervical smear - mild inflammation
  • Cervical smear - moderate dyskaryosis
  • Cervical smear - moderate inflammation
  • Cervical smear - severe dyskaryosis
  • Cervical smear - severe inflammation
  • Cervical smear - viral inflammation unspecified
  • Cervical smear transformation zone cells absent
  • Cervical smear transformation zone cells present
  • Cytology finding absent
  • Cytology findings present
  • Dyskaryosis on cervical smear
  • Severe dyskaryosis on cervical smear cannot exclude invasive carcinoma
  • Viral changes on cervical smear

Convert R87.618 to ICD-9

  • 795.4 - Abn histologic find NEC (Approximate Flag)

Code Classification

  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
    • Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
      • Abnormal findings in specimens from female genital organs (R87)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Information for Patients


Cervical Cancer Screening

The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cancer screening is looking for cancer before you have any symptoms. Cancer found early may be easier to treat.

Cervical cancer screening is usually part of a woman's health checkup. There are two types of tests: the Pap test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix. With the Pap test, the lab checks the sample for cancer cells or abnormal cells that could become cancer later. With the HPV test, the lab checks for HPV infection. HPV is a virus that spreads through sexual contact. It can sometimes lead to cancer. If your screening tests are abnormal, your doctor may do more tests, such as a biopsy.

Cervical cancer screening has risks. The results can sometimes be wrong, and you may have unnecessary follow-up tests. There are also benefits. Screening has been shown to decrease the number of deaths from cervical cancer. You and your doctor should discuss your risk for cervical cancer, the pros and cons of the screening tests, at what age to start being screened, and how often to be screened.

  • Cervical cancer -- screening and prevention (Medical Encyclopedia)
  • HPV DNA test (Medical Encyclopedia)
  • Pap and HPV Testing - NIH (National Cancer Institute)
  • Pap smear (Medical Encyclopedia)

[Learn More]